Chemotherapy-induced Thrombocytopenia
📧 Sign up to get email alerts when something new happens for Chemotherapy-induced Thrombocytopenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2023-09-28Clinical Trial Update: A Clinical Study of Hetrombopag Olamine Tablets in Adults Receiving 21-day Cycles of Chemotherapy for Solid Tumours, Who Are Delayed for at Least 1 Week From Their Scheduled Cycle Because of Chemotherapy-induced Thrombocytopenia [Phase 3]
Phase 3 clinical trial of Hetrombopag Olamine Tablets for chemotherapy-induced thrombocytopenia in solid tumour patients was withdrawn.
-
CLINICAL_TRIALS trial_result · 2023-09-06Clinical Trial Update: Hetrombopag in Secondary Prevention of XPO-1 Inhibitor-induced Thrombocytopenia in Lymphoma [Phase 2]
Phase 2 clinical trial investigating hetrombopag for secondary prevention of thrombocytopenia induced by XPO-1 inhibitors in lymphoma patien…
-
CLINICAL_TRIALS trial_result · 2023-05-09Clinical Trial Update: Evaluating the Efficacy and Safety of QL0911 in Chemotherapy- Induced Thrombocytopenia [Phase 2, Phase 3]
Phase 2/3 trial evaluating QL0911 for chemotherapy-induced thrombocytopenia has completed.
-
CLINICAL_TRIALS trial_result · 2021-11-24Clinical Trial Update: Avatrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Adults With Active Non-Hematological Cancers [Phase 3]
Phase 3 trial update for avatrombopag in adults with chemotherapy-induced thrombocytopenia shows results upon trial completion.
-
CLINICAL_TRIALS trial_result · 2020-09-16Clinical Trial Update: A Phase Ⅲa Study of Genetically Modified Recombinant Human Interleukin-11 [Phase 3]
Phase IIIa study of a genetically modified recombinant human interleukin-11 for chemotherapy-induced thrombocytopenia has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2018-01-19Clinical Trial Update: Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Lymphoma. [Phase 3]
Phase 3 trial of romiplostim for chemotherapy-induced thrombocytopenia in adults with lymphoma was withdrawn.
-
CLINICAL_TRIALS research · 2017-10-18Clinical Trial Update: Protocol for the Infusion of Buffy Coat-derived Cryopreserved Platelets in Patients With Severe Thrombocytopenia [Phase 4]
This entry describes a Phase 4 protocol for infusing Buffy Coat-derived cryopreserved platelets to treat severe thrombocytopenia; the trial …
-
CLINICAL_TRIALS trial_result · 2017-04-19Clinical Trial Update: Study Evaluating The Effects Of Oprelvekin On Cardiac Repolarization In Subjects With Chemotherapy Induced Thrombocytopenia [Phase 2]
A Phase 2 study evaluating the effects of oprelvekin on cardiac repolarization in subjects with chemotherapy-induced thrombocytopenia was te…
-
CLINICAL_TRIALS research · 2017-02-10Clinical Trial Update: A Study of the Recombinant Human Interleukin-11 (I) (Baijieyi) for Prevention and Treatment of Chemotherapy-induced Thrombocytopenia in Patients With Malignant Tumor
Clinical trial update on recombinant human interleukin-11 (Baijieyi) for prevention and treatment of chemotherapy-induced thrombocytopenia i…
-
CLINICAL_TRIALS trial_result · 2016-05-17Clinical Trial Update: Extended Platelet Parameters as a Means to Differentiate Immune Thrombocytopenia From Hypo-proliferative Thrombocytopenias.
This completed clinical trial from Beth Israel Medical Center evaluated whether extended platelet parameters can distinguish immune thromboc…
-
CLINICAL_TRIALS trial_result · 2014-04-01Clinical Trial Update: A Study of the Safety and Efficacy of ONO-7746 in Adult Cancer Patients With Chemotherapy Induced Thrombocytopenia [Phase 1]
This clinical trial update notes the termination of a Phase 1 study of ONO-7746 in adult cancer patients with chemotherapy-induced thrombocy…
-
CLINICAL_TRIALS trial_result · 2011-06-21Clinical Trial Update: Application of AS101 for the Treatment of Thrombocytopenia in Solid Tumor Patients [Phase 2]
Phase 2 trial evaluating AS101 for chemotherapy-induced thrombocytopenia in solid tumor patients has been terminated.
-
CLINICAL_TRIALS trial_result · 2010-10-21Clinical Trial Update: Dose/ Schedule Finding Trial of Romiplostim for Chemotherapy-Induced Thrombocytopenia (CIT) in Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
A Phase 2 dose/schedule finding study evaluating romiplostim for chemotherapy-induced thrombocytopenia in non-small cell lung cancer; result…
-
CLINICAL_TRIALS trial_result · 2010-09-13Clinical Trial Update: A Dose and Schedule Finding Trial With AMG 531 for Chemotherapy Induced Thrombocytopenia (CIT) in Adults With Lymphoma [Phase 1, Phase 2]
Phase 1/2 dose-finding trial of AMG 531 for chemotherapy-induced thrombocytopenia in adults with lymphoma; the study completed and results w…